1. Home
  2. GRND vs TMDX Comparison

GRND vs TMDX Comparison

Compare GRND & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grindr Inc.

GRND

Grindr Inc.

HOLD

Current Price

$11.30

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

TMDX

TransMedics Group Inc.

HOLD

Current Price

$74.43

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRND
TMDX
Founded
2009
1998
Country
United States
United States
Employees
148
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GRND
TMDX
Price
$11.30
$74.43
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$18.80
$148.22
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
382.18
EPS
N/A
0.20
Revenue
N/A
$605,494,000.00
Revenue This Year
$23.08
$24.25
Revenue Next Year
$17.04
$18.75
P/E Ratio
N/A
$371.45
Revenue Growth
N/A
37.13
52 Week Low
$9.79
$60.11
52 Week High
$23.54
$156.00

Technical Indicators

Market Signals
Indicator
GRND
TMDX
Relative Strength Index (RSI) 37.09 48.93
Support Level $10.76 $64.90
Resistance Level $11.85 $120.60
Average True Range (ATR) 0.51 3.91
MACD -0.22 2.21
Stochastic Oscillator 33.11 92.52

Price Performance

Historical Comparison
GRND
TMDX

About GRND Grindr Inc.

Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: